Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Oncolytics Biotech Inc.
ONCY · SEC Filings
website
29
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, develo...
Price
0.4077
Market Cap
53.76 M
Float
129.36 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about ONCY
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Oncolytics Biotech Inc.
ONCY · SEC Filings
129.36 M
Float
0.4077
Price
53.76 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2026
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 7, 2025
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 12, 2024
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 3, 2023
News
TYPE
HEADLINE
FILED AT
Prospectus
TYPE
HEADLINE
FILED AT
424B5
[No Baby Shelf]* April 2026 ATM | Offering amount: $75,000,000 | Bank: Jefferies LLC
Apr 6, 2026
425
Form 425 - Prospectuses and communications, business combinations
Jan 9, 2026
424B3
UPDATED | SHARE RESALE REGISTRATION
Dec 9, 2025
424B5
October 2025 ATM
Oct 17, 2025
Registrations
TYPE
HEADLINE
FILED AT
F-10POS
Form F-10POS - Post-effective amendment to a F-10EF registration
Apr 8, 2026
F-10POS
Form F-10POS - Post-effective amendment to a F-10EF registration
Apr 8, 2026
F-10POS
Form F-10POS - Post-effective amendment to a F-10EF registration
Apr 8, 2026
F-10POS
Form F-10POS - Post-effective amendment to a F-10EF registration
Apr 8, 2026
F-10POS
Form F-10POS - Post-effective amendment to a F-10EF registration
Apr 8, 2026
F-10POS
Form F-10POS - Post-effective amendment to a F-10EF registration
Apr 8, 2026
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Oct 6, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Oct 6, 2026
Ownerships
TYPE
HEADLINE
FILED AT
3
McAdory John Bearden (Reporting)
Jun 3, 2026
4
Pisano Wayne (Reporting)
Jun 3, 2026
4
RIGBY JONATHAN (Reporting)
Jun 3, 2026
4
Holtham Angela (Reporting)
Jun 3, 2026
4
Parsons James T. (Reporting)
Jun 3, 2026
4
Look Kirk (Reporting)
Jun 3, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Apr 6, 2026
EFFECT
Form EFFECT - Notice of Effectiveness
Apr 2, 2026
CORRESP
Form CORRESP - Correspondence
Apr 1, 2026
LETTER
Form UPLOAD - SEC-generated letter
Apr 1, 2026
EFFECT
Form EFFECT - Notice of Effectiveness
Dec 10, 2025
CORRESP
Form CORRESP - Correspondence
Dec 5, 2025